The company
KALA BIO, Inc.
KALA · Nasdaq
KALA stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 93.6% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $126K
- Officials’ trades on record
- 0
- Institutions holding
- 13 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 220,623$382K | +160,074+264.4% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 145,152$251K | -115,909−44.4% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 101,396$175K | +71,768+242.2% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 71,542$124K | +60,733+561.9% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 41,606$72K | +30,082+261.0% |
| Qube Research & Technologies Ltdnew · filed 14 Aug 2026 | 11,073$19K | +11,073 |
| GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026 | 10,921$19K | -3,127−22.3% |
| UBS Group AGreduced · filed 13 Aug 2026 | 9,057$16K | -57,814−86.5% |
| Tower Research Capital LLC (TRC)new · filed 11 Aug 2026 | 616$1,066 | +616 |
| BARCLAYS PLCnew · filed 14 Aug 2026 | 608$1,052 | +608 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.